I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

I am a healthcare professional in Belgium

Required field.

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology ARVO 2026
Roche and Genentech at

ARVO 2026

May 03 - May 07
Denver, USA
arvo.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:00 PM
Duration 105mins Denver, USA
Vision Gains With Faricimab▼ vs Aflibercept 2 mg in Patients With Treatment-Naïve nAMD Who Had Small Lesions: A TENAYA/LUCERNE Post Hoc Analysis
Eric Nudleman, Nicholas Dagincourt, Florie Mar, Shriji Patel, Philippe Margaron
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Analysis of foveal avascular zone morphology and clinical associations following faricimab▼ in treatment-naïve DME: An ALTIMETER OCTA post hoc analysis
Aude Couturier, Hugo Le Boité, Mathias Gallardo, Andrew Eap, Kara Gibson, Ming Yang, Shriji Patel, Bjoern Titz, Acner Camino Benech, Claudia Vazquez-Lombardi
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Assessment of intraretinal cyst turbidity on OCT: clinical implications in DME from YOSEMITE/RHINE
Jennifer Lim, Isabel Bachmeier, Yaniv Cohen, Ali Boushehri, Manuel Amdaor, Alexandra Warter, Nicholas Dagincourt and Kara Gibson
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Association of quantitative UWFA features with clinical parameters in patients with DME from the phase 3 YOSEMITE/RHINE trials
Penina Schlesinger, Karen Matar, Kara Gibson, Nicholas Dagincourt, Florie Mar, Manuel Amador, Dawn Sim, Justis P. Ehlers
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Early Real-World Effectiveness and Safety of Faricimab▼ in Eyes With RVO: 6 Month Results From the UK FARWIDE-RVO Study
Varma D, Kiire C, Sivaprasad S, Pearce I, Talks J, Gale R, Downey L, Chi G, Darnell A, Downey A, Dodds M, Dayal P
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Anatomical outcomes of faricimab▼ in patients with diabetic macular edema: 6-month real-world imaging from the VOYAGER study
Finger R, Chaudhary V, Schmitz-Valckenberg S, Parravano M, Bailey C, Chaikitmongkol V, Sredar N, Chi G, Downey A, Ishida S, Uschner D, Koh A, Lovestam-Adrian M, Luna Pinto J, Schweitzer J, Sheth V, Souied E, Guymer R
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Updated 2-Year Real-World Clinical Outcomes From an Enriched Population in Patients With Neovascular Age-Related Macular Degeneration Treated With Faricimab▼ in the US: The FARETINA-nAMD Study
Ali F, Borkar D, Bonine N, Ko S, Ahmed A, Amador M, Patel S, Zwick E, Toth J, Leng T, Singh R
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Updated 2-Year Real-World Clinical Outcomes From an Enriched Population in Patients With Diabetic Macular Edema Treated With Faricimab▼ in the US: The FARETINA-DME Study
Patel S, Singh R, Bonine N, Ko S, Ahmed A, Amador M, Zwick E, Toth J, Ali F, Leng T, Borkar D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Real-World Clinical Outcomes in Patients With Retinal Vein Occlusion With Macular Edema Treated With Faricimab▼ in the Academy IRIS® Registry
Liu A, Bonine N, Borkar D, Ko S, Ahmed A, Amador M, Patel S, Toth J, Zwick E, Singh R
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Endocrinologist involvement in Diabetic Macular Edema (DME) management and the value of extended-interval therapy in the United States: results from a real-world survey
Ko S, Bonine N, Mascia D, Coak E, Hodgkinson E, Chowdhury M, Cooper B
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Real-World Outcomes in Individuals with Diabetic Macular Edema Utilizing Faricimab▼: A Linked Analysis of Administrative Claims and IRIS Registry EHR Data
Cooper B, Ko S, Sun X, Clubb J, Ahmed A, Moore B, Lupton L, Dai D, Liu Y, Wu Y, Bonine N
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Measuring the Diabetic Eye Disease Care Continuum - Who Is Falling Through the Care Gaps?
Kim J, Ko S, Dixon R, Crocker K, Tan J, Ahmed A, Warter A, Knuth K, Ayati A, Brodie F, Tabano D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Patient preference for the PDS vs intravitreal injections: year 2 results from the phase 3 Pagoda trial in patients with diabetic macular edema (DME)
D Marcus, M Chang, A Koh, K Baldonado, A Daly, M Jones, A Lin, A Prager, G Wallenstein, K Tian
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Model-Based Pharmacokinetic Simulations of the Port Delivery Platform With Ranibizumab (PDS) Under Real-World Clinical Scenarios
Tu Mai, Katie F. Maass, Joy C. Hsu, Andrew Gordon, Ashwini Bobbala, Paul Latkany
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema - Diabetic Retinopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
Retinal fluid, thickness, and leakage in PDS-treated study eyes vs intravitreal injection-treated fellow eyes in bilateral DME in the Pagoda trial
Yi-Ting Hsieh, David Eichenbaum, Jordan M. Graff, Jason Hsu, Patricia Udaondo, Robert S. Wirthlin, Ashwini Bobbala, Shamika Gune, Dominic Heinrich, Melissa K. Jones, Amy Lin
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
The molecular pathophysiology of uveitic macular edema: an exploratory analysis from the DOVETAIL vamikibart phase 1 study
Zeinab Barekati, Juliane Siebourg-Polster, Federica Storti, Andreas Dieckmann, Meike Pauly-Evers, William Holmes, Gregor Jordan, Denise Sicker, Benedicte Passemard, Laura Steeples, David Silverman, Sascha Fauser, Marina Mesquida
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins Denver, USA
First report of the baseline characteristics of participants with uveitic macular edema in the vamikibart phase 3 MEERKAT and SANDCAT trials
Lyndell Lim, Quan Dong Nguyen, Nisha Acharya, Kathryn Pepple, Rahul N. Khurana, Carlos Pavesio, Koh-Hei Sonoda, Meike Pauly-Evers, Saima Muzaffar, Deanna Galloway, Marina Mesquida, Zdenka Haskova, David Silverman, Andre Vicente, Laura Steeples, Eric Suhler
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 15mins Denver, USA
Robust Vision Gain and Anatomic Improvement With Faricimab▼ in Patients With Polypoidal Choroidal Vasculopathy: Week 48 Results From SALWEEN
Timothy Y. Y. Lai, Gemmy Cheung, Shih-Jen Chen, Tomohiro Iida, Adrian Hock Chuan Koh, Junyeop Lee, Won Ki Lee, Xiaorong Li, Paisan Ruamviboonsuk, Xiaodong Sun, Yasuo Yanagi, Ruobing Bai, Anh Nguyen Duc, Philippe Margaron
Ophthalmology | Polypoidal Choroidal Vasculopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:30 PM
Duration 15mins Denver, USA
Baseline biomarker levels in underrepresented patients with DME: a post hoc exploratory analysis of ELEVATUM
Christiana Dinah, Jeremiah Brown, Jennifer Lim, Adrienne Scott, Thomas Albrecht, Manuel Amador, Michael Chang, Huanxiang Lu, Alexandra Warter, Ming Yang
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:15 PM
Duration 15mins Denver, USA
Long-Term Effectiveness and Safety of Faricimab▼ in Eyes With DME: 2-Year Results From the UK FARWIDE-DME Study
Peto T, Kiire C, Sivaprasad S, Reynolds R, Bailey C, Downey L, Pearce I, Chi G, Downey A, Darnell A, Dodds M, Dayal P
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:30 PM
Duration 15mins Denver, USA
Impact of Early Changes in Quantitative Ultra-Widefield Fluorescein Angiography Features on Longitudinal Vision and Anatomy in Diabetic Macular Edema Eyes From YOSEMITE/RHINE
Karen Matar, Penina Schlesinger, Kara Gibson, Nicholas Dagincourt, Florie Mar, Manuel Amador, Dawn Sim, Justis P. Ehlers
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:45 PM
Duration 15mins Denver, USA
Faricimab▼ Reduces Hard Exudates and Microaneurysms vs Aflibercept 2 mg in YOSEMITE/RHINE Using Automated Segmentation on Color Fundus Photography in DME
Samir Patel, Andreas Pollreisz, Prethy Rao, Christiana Dinah, Dawn Sim, Ming Yang, Acner Camino Benech, Kara Gibson, Fethallah Benmansour
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 15mins Denver, USA
Long-Term Effectiveness and Safety of Faricimab▼ in Eyes With nAMD: 2-Year Results From the UK FARWIDE-nAMD Study
Mukherjee R, Varma D, Talks J, Patel P, De Silva S, Gale R, De Salvo G, Chi G, Downey A, Darnell A, Dodds M, Dayal P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:00 PM
Duration 15mins Denver, USA
Automated quantification of retinal fluid volume in patients with DME: analysis of faricimab▼ vs aflibercept in YOSEMITE/RHINE
Prethy Rao, Katherine Talcott, Stela Vujosevic, Colin Tan, Gavin Tan, Kara Gibson, Derrek Hibar, Thomas Albrecht, Huanxiang Lu, Katie Litts, Ming Yang, Nancy Holekamp
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:15 PM
Duration 15mins Denver, USA
Four-year outcomes of faricimab▼ in nAMD: safety and efficacy results from the AVONELLE-X long-term extension trial
Niro Narendran, Shriji Patel, Arshad M. Khanani, Marta S. Figueroa, Robyn Guymer, Timothy Y. Y. Lai, Andrew Lotery, Patricio Schlottmann, Veeral Sheth, Charles C. Wykoff, Ruobing Bai, Philippe Margaron, Yannan Tang, Aachal Kotecha
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 15mins Denver, USA
RHONE-X extension study: clinical improvements in eyes with DME switched from aflibercept 2 mg to faricimab▼
Murtaza Adam, Colin Tan, Roger Goldberg, Ian Pearce, Veeral Sheth, Arshad Khanani, Cheryl Jones, Kara Gibson, Dawn Sim
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:30 PM
Duration 15mins Denver, USA
Anatomical Outcomes of Faricimab▼ in Patients With Neovascular Age-Related Macular Degeneration: 6 Month Real-World Imaging From the VOYAGER Study
Ishida S, Schmitz-Valckenberg S, Parravano M, Bailey C, Chaikitmongkol V, Chaudhary V, Chi G, Downey A, Finger R, Albrecht T, Uschner D, Koh A, Lovestam-Adrian M, Luna Pinto J, Schweitzer J, Sheth V, Souied E, Guymer R
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:45 PM
Duration 15mins Denver, USA
Reduction in Subretinal Hyperreflective Material Volume With Faricimab▼ vs Aflibercept 2 mg in treatment-Naïve nAMD: A TENAYA/LUCERNE Post Hoc Analysis
Srinivas Sadda, Jesse Jung, Isabel Bachmeier, Anh Nguyen Duc, Lei Han, Andreas Maunz, Shriji Patel, Siqing Yu, Philippe Margaron
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:30 PM
Duration 15mins Denver, USA
Efficacy and Safety of Vamikibart in Patients With Diabetic Macular Edema: First Results From the Phase 2 ALLUVIUM Trial
Arshad Khanani, David Eichenbaum, Roberto Gallego-Pinazo, Meike Pauly-Evers, Zeinab Barekati, Yaqing Sun, Emma Harrell, Laura Steeples, Zdenka Haskova, David Silverman, Sascha Fauser, Marina Mesquida
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:45 PM
Duration 15mins Denver, USA
Efficacy and Safety of Vamikibart in Combination With Ranibizumab in Patients With DME: First Results From the Phase 2 BARDENAS Trial
Roger Goldberg, Allen Hu, Charlie Wykoff, Meike Pauly-Evers, Zeinab Barekati, Yaqing Sun, Emma Harrell, Laura Steeples, Zdenka Haskova, David Silverman, Sascha Fauser, Marina Mesquida
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:00 PM
Duration 15mins Denver, USA
One-year outcomes of faricimab▼ patients with DME from a global, prospective observational study: the VOYAGER study
Monica Lovestam-Adrian, Chaudhary V, Schmitz-Valckenberg S, Parravano M, Bailey C, Chakitmongkol V, Chi G, Downey A, Finger R, Ishida S, Uschner D, Koh A, Luna Pinto J, Schweitzer J, Souied E, Sheth V, Guymer R
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:45 PM
Duration 15mins Denver, USA
Efficacy and safety of vamikibart in patients with uveitic macular edema: anatomical outcomes at Week 16 in the phase 3 MEERKAT and SANDCAT trials
Eduardo Uchiyama, Rahul Khurana, Nisha Acharya, Carlos Pavesio, Koh-hei Sonoda, Eric Suhler, Steeples L, Galloway D, Haskova Z, Harrell E, Mesquida M, Silverman D.
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:30 PM
Duration 15mins Denver, USA
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic Macular Edema at 1 and 2 Years: A Systematic Literature Review and Network Meta-Analysis
Tan C, Barakat M, Siedlecki J, Arrigo A, Buehrer C, Cox C, Gibson K, Holekamp K, Patel S, Mar F
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:45 PM
Duration 15mins Denver, USA
Greater Anatomical Improvements With Faricimab▼ vs Aflibercept 2 mg at 4 and 8 Weeks After Injections in Treatment-naïve nAMD
Talisa Forest, Manjot K. Gill, Varun Chaudhary, Avni Finn, Nicholas Dagincourt, Shriji Patel, Philippe Margaron
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:15 PM
Duration 15mins Denver, USA
One-year Outcomes of Faricimab▼ Treatment in Eyes With nAMD From the Global, Prospective Observational VOYAGER Study
Aboobaker S, Sheth V, Schmitz-Valckenberg S, Parravo M, Bailey C, Chaikitmongkol V, Chaudhary V, Chi G, Downey A, Ishida S, Uschner D, Koh A, Lovestam-Adrian M, Luna Pinto J, Schweitzer J, Souied E, Guymer R
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:30 PM
Duration 15mins Denver, USA
Machine Learning–Based 3D Volumetric Analysis of Pigment Epithelial Detachment Reduction With Faricimab▼ vs Aflibercept 2 mg in TENAYA/LUCERNE
Sam Minaker, Paolo Lanzetta, Yoshihiro Yonekawa, Thomas Albrecht, Derrek Hibar, Huanxiang Lu, Shriji Patel, Ming Yang, Philippe Margaron
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:00 PM
Duration 15mins Denver, USA
Interim Analysis of the Belvedere nAMD Study: Summary of PDS Treatment in Eyes With High Injection Burden
Robert Wirthlin, Shamika Gune, Andrew Gordon, Steve Blotner, Brianne Chin
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.